Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
MDAI 
Spectral AI Inc. (MDAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/03/2025: MDAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5.36
1 Year Target Price $5.36
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -49.67% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 46.03M USD | Price to earnings Ratio - | 1Y Target Price 5.36 |
Price to earnings Ratio - | 1Y Target Price 5.36 | ||
Volume (30-day avg) 3 | Beta 0.91 | 52 Weeks Range 1.04 - 3.25 | Updated Date 12/3/2025 |
52 Weeks Range 1.04 - 3.25 | Updated Date 12/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.75 |
Earnings Date
Report Date 2025-11-12 | When - | Estimate -0.085 | Actual -0.1384 |
Profitability
Profit Margin -70.64% | Operating Margin (TTM) -88.11% |
Management Effectiveness
Return on Assets (TTM) -34.71% | Return on Equity (TTM) -2308.32% |
Valuation
Trailing PE - | Forward PE 52.36 | Enterprise Value 48579120 | Price to Sales(TTM) 1.99 |
Enterprise Value 48579120 | Price to Sales(TTM) 1.99 | ||
Enterprise Value to Revenue 2.1 | Enterprise Value to EBITDA -3.41 | Shares Outstanding 30688895 | Shares Floating 22865682 |
Shares Outstanding 30688895 | Shares Floating 22865682 | ||
Percent Insiders 25.64 | Percent Institutions 9.61 |
Upturn AI SWOT
Spectral AI Inc.
Company Overview
History and Background
Spectral AI, Inc. was founded in 2008 and is focused on developing and commercializing advanced diagnostic technologies for assessing burn wounds and predicting patient outcomes. The company aims to improve burn care through non-invasive, real-time assessment of tissue viability.
Core Business Areas
- Burn Assessment Technology: Spectral AI's primary business revolves around developing and commercializing the DeepViewu00ae System, which utilizes spectral imaging to assess burn wound severity and predict healing potential. They provide associated software, services, and consumables.
Leadership and Structure
The leadership team includes key executives responsible for technology development, commercialization, and operations. The organizational structure consists of departments focusing on research and development, sales and marketing, regulatory affairs, and manufacturing.
Top Products and Market Share
Key Offerings
- DeepViewu00ae System: The DeepViewu00ae System uses proprietary spectral imaging technology to assess burn wound severity and predict healing. Competitors include companies offering alternative burn assessment methods, such as clinical evaluation, laser Doppler imaging, and biopsy. Market share data is currently unavailable for DeepView, but they are working to increase market penetration and adoption.
Market Dynamics
Industry Overview
The burn care market involves treating patients with burn injuries, often requiring specialized medical care. The industry includes hospitals, burn centers, and medical device companies that provide diagnostic and therapeutic solutions.
Positioning
Spectral AI is positioned as an innovative technology provider in burn assessment. Their competitive advantage lies in the non-invasive, real-time nature of their DeepViewu00ae System and its ability to provide objective data on tissue viability to aid in burn treatment decisions.
Total Addressable Market (TAM)
The global burn care market is estimated to be billions of dollars. Spectral AI is positioned to capture a share of this market by offering a more accurate and efficient burn assessment tool.
Upturn SWOT Analysis
Strengths
- Proprietary spectral imaging technology
- Non-invasive and real-time assessment
- Potential to improve burn care outcomes
- Strong intellectual property portfolio
- FDA approval/clearance
Weaknesses
- Limited market penetration
- High initial cost of the DeepViewu00ae System
- Dependence on adoption by burn centers
- Limited clinical data compared to standard methods
Opportunities
- Expanding market presence in the US and internationally
- Developing new applications for spectral imaging technology
- Collaborating with burn centers and research institutions
- Increasing awareness and education about DeepViewu00ae System
- Securing reimbursement from insurance providers
Threats
- Competition from existing burn assessment methods
- Technological advancements by competitors
- Regulatory changes affecting medical devices
- Economic downturn impacting hospital budgets
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- Smith & Nephew (SNN)
- Integra LifeSciences (IART)
- Mu00f6lnlycke Health Care (Private)
Competitive Landscape
Spectral AI has an advantage with its DeepView technology, but faces challenges from established players with broader product portfolios and market access.
Growth Trajectory and Initiatives
Historical Growth: Historical growth depends on commercial adoption of DeepViewu00ae System.
Future Projections: Future projections depend on commercial adoption of DeepViewu00ae System and market penetration, with potential for significant growth.
Recent Initiatives: Recent initiatives include commercializing the DeepViewu00ae System in burn centers, clinical trials, and pursuing regulatory approvals.
Summary
Spectral AI is a promising company with innovative burn assessment technology, DeepView, which has the potential to improve burn care. However, its success depends on securing commercial adoption and market penetration. Spectral AI needs to carefully manage competition from larger players and navigate regulatory and reimbursement challenges to achieve its growth potential. They must show positive commercial adoption and clinical acceptance.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Spectral AI Investor Relations
- Company Filings
- Industry Reports
- Market Analysis
Disclaimers:
This analysis is based on available information and is subject to change. It does not constitute investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Spectral AI Inc.
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2021-04-06 | Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO Mr. Wensheng Fan | ||
Sector Healthcare | Industry Medical Devices | Full time employees 78 | Website https://www.spectral-ai.com |
Full time employees 78 | Website https://www.spectral-ai.com | ||
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.